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Abstract
Measurements of integral membrane protein lateral mobil-
ity and rotational mobility have been separately used to
investigate dynamic protein-protein and protein-lipid in-
teractions that underlie plasma membrane structure and
function. In model bilayer membranes, the mobilities of re-
constituted proteins depend on the size of the diffusing mole-
cule and the viscosity of the lipid bilayer. There are no direct
tests, however, of the relationship between mechanisms that
control protein lateral mobility and rotational mobility in
intact biological membranes. We have measured the lateral
and rotational mobility of band 3 in spectrin-deficient red
blood cells from patients with hereditary spherocytosis and
hereditary pyropoikilocytosis. Our data suggest that band
3 lateral mobility is regulated by the spectrin content of the
red cell membrane. In contrast, band 3 rotational mobility
is unaffected by changes in spectrin content. Band 3 lateral
mobility and rotational mobility must therefore be con-
trolled by different molecular mechanisms. (J. Clin. Invest.
1994. 94:683-688.) Key words: erythrocyte membrane * he-
reditary spherocytosis - hereditary pyropoikilocytosis flu-
orescence photobleaching recovery polarized fluorescence
depletion
Introduction
The fluid-mosaic model of membrane structure postulates that
randomly distributed transmembrane proteins are free to diffuse
within the membrane at rates determined by the viscosity of a
homogeneous lipid milieu (1). This model has proved correct
for model bilayer membranes, in which the mobilities of recon-
stituted proteins depend only on the size of the diffusing mole-
cule and the viscosity of the lipid bilayer (2-5). In biological
membranes, however, there appear to be additional constraints
on the mobility and distribution of integral membrane proteins,
including interactions with heterogeneously distributed mem-
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brane lipids and with other integral or peripheral membrane
proteins (6, 7).
The human red blood cell (RBC)' membrane is a prototypi-
cal biological membrane composed of a lipid bilayer, in which
integral membrane proteins are embedded, and a multicompo-
nent protein skeleton that laminates the inner bilayer surface
(8). Band 3, the RBC anion exchanger (9), is the major protein
component of the RBC membrane (10) and the major site of
attachment between the membrane skeleton and the bilayer (1 1).
Spectrin, the major skeletal protein, is attached to the overlying
bilayer through interactions involving ankyrin, which links
spectrin to a portion (10-15%) of band 3, and protein 4.1,
which links spectrin to glycophorin C (12, 13) and possibly to
glycophorin A (14, 15) and band 3 (16).
40-70% of band 3 molecules are free to diffuse laterally
in the normal intact RBC membrane. The mobile fraction of
band 3 diffuses laterally at a rate of 1-2 X 10-11 cm2 s-' (17-
19). In contrast, RBC phospholipid analogues have fractional
mobilities of 90-100% and translational diffusion coefficients
of 1-5 x 10-9 cm2 S-' (17, 20). Abundant evidence implicates
the RBC membrane skeleton in controlling band 3 lateral mobil-
ity. Disruption of spectrin-ankyrin and ankyrin-band 3 link-
ages causes band 3 mobility to increase (21-24), as does treat-
ment with proteases to remove the cytoplasmic domain of band
3 (25, 26) or treatment with ATP or 2,3-DPG (27) at levels that
are sufficient to destabilize isolated RBC membrane skeletons
(28). Oxidative crosslinking of spectrin induces slowing of band
3 diffusion (17, 29). Finally, band 3 is translationally immobile
in Southeast Asian ovalocytosis (SAO) RBCs, in which band
3 forms linear stacks of oligomers in the plane of the membrane
(30)2 and structurally and functionally abnormal band 3 mole-
cules bind more tightly than normal band 3 to ankyrin (18,
31 33).2
Band 3 rotational mobility has been studied in normal RBC
ghosts (26, 34-44), abnormal RBC ghosts (45, 46), and intact
RBCs (19, 31, 37).2 Rapidly rotating, slowly rotating, and rota-
tionally immobile forms of band 3 appear to coexist in the
membrane. At 37°C in normal RBC membranes, 20-25% of
band 3 molecules rotate with correlation times (r) < 250 Ms,
50-75% rotate with r 1-3 ms, and 5-25% are rotationally
immobile on the time scale of the experiment (19, 37, 40).
1. Abbreviations used in this paper: FPR, fluorescence photobleaching
recovery; HPP, hereditary pyropoikilocytosis; HS, hereditary spherocy-
tosis; KPBS, high potassium phosphate-buffered saline; PFD, polarized
fluorescence depletion; RBC, red blood cell; SAO, Southeast Asian
ovalocytosis.
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About half of the rapidly rotating band 3 molecules may rotate
with correlation times of 25-30 ,ts; this population could repre-
sent band 3 dimers rotating free of constraints other than the
viscosity of the lipid bilayer (37). A number of experiments on
RBC ghost membranes suggest that band 3 rotational mobility,
like band 3 lateral mobility, is controlled by the RBC membrane
skeleton (26, 36, 37, 43). In addition, SAO RBCs exhibit a very
large fraction of rotationally immobile band 3 (30, 31, 46).2
Studies correlating defined molecular abnormalities in mem-
brane skeletal proteins with band 3 mobility in intact RBCs
from patients with hereditary hemolytic anemias provide unique
opportunities to elucidate relationships among membrane skele-
tal interactions controlling band 3 lateral mobility and rotational
mobility. In this study, we measure the lateral and rotational
mobility of fluorescently labeled band 3 in matched samples of
spectrin deficient RBCs from patients with hereditary spherocy-
tosis (HS) and hereditary pyropoikilocytosis (HPP). We find
that band 3 lateral diffusion rates are inversely proportional to
the spectrin content of the RBC membrane. In contrast, band 3
rotational mobility is not affected by changes in spectrin con-
tent. Band 3 lateral mobility and rotational mobility must there-
fore be regulated by different molecular mechanisms.
Methods
Eosin maleimide was purchased from Molecular Probes, Inc. (Eugene,
OR). Glucose oxidase and catalase were obtained from Sigma Chemical
Co. (St. Louis, MO). Fresh blood was collected by venipuncture, antico-
agulated with acid/citrate/dextrose, and shipped on ice to Boston, MA
by overnight courier. Within 24 h of venipuncture the buffy coat was
removed by aspiration and RBCs were washed 3 times and stored at
40C in high potassium phosphate-buffered saline (KPBS) (140 mM KCl,
15 mM NaPO4, 10 mM glucose, pH 7.4). High potassium buffers were
used to prevent possible cellular dehydration associated with deoxygen-
ation and fluorescent labeling.
Biochemical analysis ofRBC membranes. The spectrin/band 3 ratio
in HS, HS carrier, HPP, HPP carrier, and control RBC membranes
was measured by densitometric scans of Coomassie blue-stained SDS-
polyacrylamide gels, as described (47, 48). The range of spectrin/band
3 ratios for control RBC membranes was 0.95-1.05 (raw data), and
experimental values were normalized to a control ratio of 1.00. The
spectrin content of HS, HS carrier, and control RBC membranes was
also measured by spectrin radioimmunoassay, as described (49, 50).
Specific labeling ofRBC band 3. 100 ml of freshly washed packed
RBCs were incubated with 40 ml of eosin maleimide, 0.25 mg/ml in
KPBS, at room temperature for 12 min. Cells were then washed 3 times
in KPBS with 1% BSA. Under these labeling conditions > 80% of the
membrane-associated fluorescence was covalently bound to band 3 (51).
Lateral mobility measurements. Fluorescence photobleaching recov-
ery (FPR) (52) was used to measure the lateral mobility of eosin labeled
band 3 in membranes of intact RBCs. A Gaussian laser beam was
focused to a spot on a labeled RBC in a fluorescence microscope.
After a brief, intense photobleaching pulse, recovery of fluorescence
was monitored by periodic low intensity pulses. Fluorescence recovery
resulted from the lateral diffusion of unbleached fluorophores into the
bleached area. Nonlinear least-squares analysis (53) of fluorescence re-
covery data yielded both the diffusion coefficient and the fraction of
labeled band 3 molecules that were free to diffuse on the time scale of
the experiment (17). Details of the electronics and optics used in our
FPR apparatus have been published (19). All measurements were per-
formed at 37°C.
Rotational mobility measurements. Polarized fluorescence depletion
(PFD) (54) was used to measure the rotational mobility of eosin labeled
band 3 in membranes of intact RBCs. Eosin molecules were photose-
lected to the triplet state by an intense polarized laser pulse. The decay
A Fig. 1. Typical FPR curves
1500 depicting the lateral mobility
of band 3 in intact RBCs
M 1050 H5 from patients with HS (A)
,u . and controls (B). Normalized
Fiuci~l spectrin/band 3 ratios in the6. Prleach | HS and control samples were
0.70 and 1.00, respectively.
1500 B Data points represent fluo-
rescence counts at experi-
= lo50- . _ mental times before and after° the photobleaching pulse.
N*tControl Spectrin-deficient HS RBCs
600 showed increased lateral dif-
fusion coefficients relative to
Time200 300 400 control RBCs, indicating in-
creased freedom of band 3
lateral movement. HS, diffu-
sion coefficient = 12 x 10-"1 cm2 so', fractional mobility = 78%.
Control, diffusion coefficient = 1.6 x 10-"1 cm2 s-', fractional mobility
= 70%.
of induced anisotropy was measured by monitoring ground state fluo-
rescence oriented parallel and perpendicular to the photoselection pulse
(37, 54, 55). Using our laser microscope photometer two exponential
components of anisotropy decay and a residual anisotropy could be
resolved, so data were fitted by nonlinear least squares analysis to the
equation: r(t) = r(oc) + a exp(-t'Ty) + f exp(-t/r2), where r(t) is the
anisotropy at time t, r(cx) is the residual anisotropy, and a and /3 are
the fractions of molecules with rotational correlation times Tj and T2,
respectively. An enzyme oxygen scavenging system, consisting of 50
U/ml glucose oxidase, 20 mM glucose, and 104 U/ml catalase, served
to eliminate oxygen from the sample and thereby prevent quenching of
the excited triplet state of eosin (55). Slides were prepared for PFD
experiments by placing 3.2 Mil of a 10% RBC suspension on a BSA-
coated glass slide and using vacuum grease to seal a BSA-coated cov-
erslip over the sample. Details of the electronics and optics used in
our PFD apparatus have been published (19). All measurements were
performed at 370C.
Results
We measured by FPR the lateral mobility of band 3 in intact
RBCs from 8 patients (47) with severe, recessively inherited
spherocytosis, 2 carriers of HS, and 10 controls with normal
RBC morphology. HS RBCs had spectrin contents by radioim-
munoassay of 31-59% of control values and spectrin/band 3
ratios of 43-73% of control values (47, 49, 50, 56). Representa-
tive FPR curves for normal and spectrin deficient HS cells are
shown in Fig. 1. When the logarithm of the band 3 diffusion
coefficient was plotted against RBC spectrin content for HS,
HS carrier, and control cells, an inverse linear relationship was
observed with R2 = 0.81 (Fig. 2 A). Control diffusion coeffi-
cients were 0.7-2.4 x 10-11 cm2 s-', and the maximum ob-
served diffusion coefficient was an order of magnitude greater.
The extrapolated diffusion coefficient at 0% spectrin was 110
x 10-I cm2 s-', which is of the same magnitude as the band
3 "rapid diffusion limit" previously observed in RBC ghosts
(23, 24, 51). The results in RBCs from two HS carriers did not
differ from those in RBCs from unrelated controls or from the
results in RBCs from the splenectomized control. These data
suggest that the rate of band 3 lateral diffusion is regulated
primarily by RBC membrane spectrin content. Fractional mobil-
ities of band 3 showed no significant correlation with RBC
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Fig. 2. Dependence of band 3 lateral diffusion rate on normalized
spectrin/band 3 ratio in intact RBCs from patients with HS (A) and HPP
(B). Data points represent mean lateral diffusion coefficients of band 3
in membranes of 8-12 cells from one individual. The average SD for
each data point was 48% (range, 24%-73%). Filled symbols represent
splenectomized individuals, open symbols indicate spleen retained. (Ab-
scissa) Normalized ratio of spectrin to band 3 measured by densitometric
scans of Coomassie blue stained SDS-polyacrylamide gels (47). (Ordi-
nate) Band 3 lateral diffusion coefficient. Equations of best fit and
correlation coefficients were: HS, In (diffusion coefficient) = 4.5 -
0.040 (spectrin/band 3), R2 = 0.81; HPP, In (diffusion coefficient) =
5.1 - 0.049- (spectrin/band 3), R2 = 0.69. (C) Dependence of band 3
fractional mobility on normalized spectrin/band 3 ratio in intact RBCs
from patients with HS and HPP, carriers of HS and HPP, and controls.
Data points represent mean fractional mobility of band 3 in membranes
of 8-12 cells from one individual. The average SD for each data point
was 18% (range, 9%-36%). (Abscissa) Normalized ratio of spectrin to
band 3 measured by densitometric scans of Coomassie blue stained
SDS-polyacrylamide gels (47). (Ordinate) Band 3 fractional
0.0 0.5 1.0 1.5 2.0
Time (ms)
Fig. 3. Typical PFD curves
showing the rotational mo-
bility of band 3 in intact
RBCs from patients with HS
(A) and controls (B). Nor-
malized spectrin/band 3 ra-
tios in the HS and control
samples were 0.68 and 1.00,
respectively. Data from
300 cells were collected
to obtain each curve. HS and
control RBCs exhibited band
3 rotational mobilities that
were not significantly differ-
ent from one another. HS, a
= 22%, ri = 147 Ps, ,l
= 70%, Tr2 = 1-9 Ms, r(cc)
= 8%. Control, a = 27%, r
= 71 Mis, = 58%, r2 = 1.3
ms, r(cx) = 15%.
spectrin content (Fig. 2 C). These data suggest that molecular
interactions responsible for lateral immobilization of band 3,
such as high-affinity binding of a fraction of band 3 to ankyrin
(57), remain intact in HS RBCs.
We measured by PFD the rotational mobility of band 3 in
intact RBCs from four of the patients with severe HS and two
controls with normal RBC morphology. Control RBCs had 3
populations of band 3 molecules, including 25% rapidly ro-
tating molecules (-r, - 100 bs), 60% slowly rotating mole-
cules (r2, - 1.5 ms), and - 15% rotationally immobile mole-
cules. Spectrin-deficient HS RBCs had populations and correla-
tion times of rapidly rotating, slowly rotating, and rotationally
immobile band 3 molecules that were not significantly different
from those in control RBCs (Fig. 3; Table I). These data indicate
that specific binding interactions between band 3 and spectrin
do not exist. If such interactions were present, a reduction in
spectrin content would be expected to result in an increase in
band 3 rotational mobility.
We also measured by FPR the lateral mobility of band 3 in
intact RBCs from five patients with HPP and four carriers of
HPP (48). HPP RBCs manifested moderate reductions in mem-
brane spectrin content (spectrin/band 3 ratios, 68-80% of con-
trol values). In addition, because the molecular defect in these
HPP RBCs involved mutations in the spectrin a-l domain, the
phenotype included weakened spectrin dimer-dimer associa-
tion (48, 58-60). These RBCs exhibited band 3 lateral diffusion
coefficients similar to those of HS and HS carrier RBCs with
the same degree of spectrin deficiency. When the logarithm of
the band 3 diffusion coefficient was plotted against spectrin
content for HPP and HPP carrier cells, an inverse linear relation-
ship was obtained with slope and rapid diffusion limit similar
to those found for HS RBCs (Fig. 2 B). Since HPP and HPP
carrier RBCs defective in the spectrin dimer-dimer interaction
manifested diffusion coefficients identical to those of HS and
mobility. The lateral diffusion coefficient of band 3 was inversely
proportional to RBC spectrin content in HS and HPP RBCs, whereas
the fraction of laterally mobile band 3 molecules did not depend on
spectrin content.














Table I. Rotational Mobility of Band 3 in HS and Control RBCs
Spectrin/Band
Sample 3 ratio a r, / r2 r(X)
% As % ms %
HS-1 0.54 25 89 70 2.2 5
HS-2 0.68 22 147 70 1.9 8
HS-3 0.72 26 50 61 1.2 13
HS-4 0.74 28 44 50 1.2 22
Control-I 1.00 18 50 63 1.4 8
Control-2 1.00 27 71 58 1.3 15
PFD (21) was used to measure the rotational mobility of eosin labeled
band 3 in intact RBCs from four patients with HS and two controls
with normal RBC morphology. Experiments were performed at 370C.
Rotational mobility parameters were determined by nonlinear least-
squares analysis. Chi-square values ranged from 0.17 to 0.42 for the
equations corresponding to the best fit curves. a and /3, fractions of
band 3 molecules rotating with correlation times ri and T2, respectively.
r(oo), fraction of rotationally immobile band 3 molecules. Normalized
spectrin/band 3 ratio was measured by densitometric scans of Coomassie
blue-stained SDS-polyacrylamide gels (47).
HS carrier RBCs with the same degree of spectrin deficiency,
the spectrin dimer-dimer interaction cannot be important for
the regulation of band 3 lateral diffusion.
Discussion
In this work, measurements of band 3 mobility in membranes
of intact RBCs from patients with two hereditary forms of he-
molytic anemia are used to investigate hypotheses for the mo-
lecular interactions that control transmembrane protein lateral
and rotational mobility. Band 3 lateral diffusion coefficients in
HS and HPP RBCs are increased compared to those in control
RBCs, and the degree of elevation in diffusion coefficient is
inversely related to the RBC spectrin content. In contrast, band
3 rotational mobility in HS RBCs is identical to that in control
RBCs. Finally, band 3 lateral mobility in HPP RBCs is similar
to that in HS RBCs with the same degree of spectrin deficiency.
Several molecular mechanisms could underlie the depen-
dence of band 3 lateral diffusion rate on RBC spectrin content.
Spectrin, a flexible rod-like protein that may wind between
junctional complexes at varying distances from the membrane
bilayer (61), could act as a molecular "fence" to retard band
3 lateral movement. Spectrin could bind directly to the cyto-
plasmic domain of band 3 in a low affinity (Kd 1-10 1tM)
interaction, or it could modulate the affinity of a direct binding
interaction between band 3 and ankyrin, protein 4.1, or another
membrane skeletal component (51). Finally, interactions be-
tween spectrin and inner leaflet phospholipids (62) could alter
the viscosity of the membrane lipid bilayer. The latter mecha-
nism is unlikely, because we found no significant difference
between the lateral diffusion coefficient or fractional mobility
of fluorescein phosphatidylethanolamine, a fluorescent phos-
pholipid analogue, in HS and control RBCs (data not shown).
Measurements of band 3 rotational mobility in HS and con-
trol RBCs suggest that mechanisms involving steric hindrance
to band 3 lateral diffusion are more likely than mechanisms
involving direct binding interactions. Lateral mobility measure-
ments provide information about long-range dynamic interac-
tions (Ium scale) between the diffusing species and membrane
protein or lipid components, whereas rotational mobility mea-
surements yield information concerning short-range dynamic
interactions (nm scale). Thus, interactions that regulate mem-
brane protein lateral mobility include specific binding, steric
hindrance, self-aggregation, heterocomplex formation, and do-
main formation (6, 63), while only direct binding interactions
and protein oligomerization appear to be important in control-
ling rotational mobility (64). Since the rotational mobility of
band 3 in spectrin-deficient HS RBCs is identical to that in
control RBCs, the average oligomerization state of band 3 can-
not be a function of RBC spectrin content, and significant bind-
ing interactions between band 3 and spectrin cannot exist. Be-
cause spectrin-band 3 interactions are critical in regulating the
lateral but not the rotational diffusion of band 3 in intact RBCs,
our data favor the steric hindrance (fence) model of lateral
mobility regulation (65) over the direct binding model (re-
viewed in reference 51). This conclusion is supported indirectly
by experiments on band 3 mobility in RBC ghost membranes
(22, 25, 26, 35, 66).
The molecular interactions that control band 3 rotational
diffusion appear to involve both band 3 self-association (aggre-
gation) in the plane of the RBC membrane (36, 41) and specific
binding interactions between the cytoplasmic domain of band
3 and membrane skeletal proteins (4, 5, 37, 67) such as ankyrin.
In spectrin-deficient HS RBCs, ankyrin binding sites on spectrin
may remain in sufficient numbers to provide restriction of band
3 rotational mobility through band 3-ankyrin complex forma-
tion. Band 3 interactions with proteins 4.1 (16) or 4.2 (68, 69),
which would not be perturbed in spectrin-deficient RBCs, could
also be responsible for rotational mobility restriction in HS
RBCs (67).
One version of the steric hindrance model for regulation of
band 3 lateral diffusion rates involves the possibility of dynamic
interconversion between spectrin dimers (open fences) and tet-
ramers (closed fences) at the inner surface of the RBC mem-
brane (70). HS and HPP RBCs share the spectrin-deficient phe-
notype. The spectrin dimer-dimer interaction is functionally
normal in HS RBCs and weakened in HPP RBCs, however. A
comparison between band 3 lateral diffusion rates in intact HS
and HPP RBCs should therefore provide a test of the importance
of the spectrin dimer-+tetramer interconversion in controlling
band 3 lateral mobility. We find that the lateral mobility of band
3 in HPP and HPP carrier RBCs is similar to that of HS and
HS carrier RBCs with the same degree of spectrin deficiency.
These data suggest that control of band 3 lateral mobility de-
pends on the absolute number of spectrin molecules in the mem-
brane skeleton and not on the state of spectrin oligomerization.
Thus, the spectrin dimer-dimer interaction is unlikely to be
important for the regulation of band 3 lateral diffusion. Steric
hindrance interactions between spectrin and band 3 must there-
fore be mediated not by alterations in the spectrin oligomeriza-
tion state but rather by other dynamic changes in spectrin struc-
ture, such as thermodynamic fluctuations of spectrin dimers
toward (closed fence) or away from (open fence) the inner
leaflet of the RBC membrane.
In conclusion, these data suggest that band 3 lateral mobility
and rotational mobility are controlled by different molecular
interactions. The spectrin-based membrane skeleton appears to
be critical in regulating the lateral (22, 66) but not the rotational
(25,26, 35) diffusion of band 3. This deduction favors the steric
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hindrance model of lateral mobility regulation (65) over the
specific binding site model (reviewed in reference 51). In con-
trast, molecular binding interactions involving the cytoplasmic
domain of band 3, including increased affinity for ankyrin (31,
46),2 increased binding of abnormal or denatured hemoglobin
(19) or glycolytic enzymes (37), and possibly oxidative cross-
linking of band 3 to large aggregates, are likely to be required
for rotational immobilization of this protein. Future studies will
define further the roles of membrane skeletal proteins that bind
directly to the cytoplasmic domain of band 3, such as ankyrin
and protein 4.2, in regulating the distribution of band 3 mole-
cules in intact RBCs among rapidly rotating, slowly rotating,
and rotationally immobile populations.
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